“We invested in Guidehealth because we believe in their vision to improve health outcomes while lowering overall costs and alleviating the administrative burdens that physicians experience when managing their patient panels,” Feby Abraham, PhD, executive vice president and chief strategy officer for Memorial Hermann said in a Aug. 6 news release.
According to the release, Guidehealth enhances access to care and improves health outcomes for patients within value-based care models through its technology platform that offers organizations AI tools and proprietary AI that create a unified care plan with predictive analytics on modifiable risks.
